Clearside Biomedical, Inc.

Release Summary

Clearside Biomedical, a clinical-stage biopharmaceutical company developing drugs for the eye, announces positive preliminary Phase 2 results in patients with macular edema associated with RVO.

Clearside Biomedical, Inc.